Management of Actinic Keratoses

Comprehensive Therapy

Volumn 29, Issue 2-3, 2003, Pages 108-114

  Lang Jr , Pearon G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; DICLOFENAC; FLUOROURACIL; HYALURONIC ACID; IMIQUIMOD; IMMUNOMODULATING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN P53; RETINOID; TRICHLOROACETIC ACID;

ACTINIC KERATOSIS; CHEILITIS; CHEMICAL PEELING; CRYOSURGERY; CURETTAGE; DESICCATION; EXCISION; HUMAN; LOW LEVEL LASER THERAPY; PHOTODYNAMIC THERAPY; REVIEW; SKIN ABRASION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; ULTRAVIOLET RADIATION;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CRYOSURGERY; DERMABRASION; DICLOFENAC; DRUG COMBINATIONS; FLUOROURACIL; HUMANS; HYALURONIC ACID; KERATOSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIVITY DISORDERS;

EID: 0142059705     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1385/COMP:29:2-3:108     Document Type: Review

References (43)

1. Stockfleth E, Meyer T, Benninghoff B, et al. Successful treatment of actinic keratosis with imiquimod cream 5%: A report of six cases. Br J Dermatol. 2001;144:1050-3.
2. Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol. 1994;131:455-64.
3. Lober BA, Lober CW. Actinic keratosis is squamous cell carcinoma. South Med J. 2000;7:650-5.
4. Engel A, Johnson ML, Haynes SG, Health effects of sunlight exposure in the United States: Results from the first national health and nutrition examination survey 1971-4. Arch Dermatol. 1988;124:72-9.
5. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:S4-7.
6. Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:S8-10.
7. Schwartz RA. The actinic keratosis: A perspective and update. Dermatol Surg. 1997;23:1009-19.
8. Jeffes EWB, III, Tang EH. Actinic keratosis. Current treatment options. Am J Clin Dermatol. 2000;3:167-79.
9. Bavinck JN, DeBoer A, Vermeer BJ, et al. Sunlight, keratotic skin lesions, and skin cancer in renal transplant recipients. Br J Dermatol. 1993;129:242-9.
10. Tucci MG, Offidani A, Lucarini G, et al. Advances in the understanding of malignant transformation of keratinocytes: An immunohistochemical study. J Eur Acad Dermatol Venereol. 1998;10:118-24.
11. Van Praag MC, Bavinick JN, Bergman W, et al. PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of non-melanoma skin cancer. J Am Acad Dermatol. 1993;28:412-7.
12. Wolf JE Jr, Taylor JR, Tschen E, et al. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol. 2001;40:709-13.
13. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42:S23-24.
14. Dobson JM, DeSpain J, Hewett JE, et al. Malignant potential of actinic keratoses and controversy over treatment: A patient-oriented perspective. Arch Dermatol. 1991;127:1029-31.
15. Cockrell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma (actinic keratosis). J Am Acad Dermatol. 2000;42:S11-7.
16. Ziegler A, Jonason AS, Lefell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature. 1994;372:773-6.
17. Nelson MA, Eiknspahr JG, Alberto DS, et al. Analysis of p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett. 1991;85:23-9.
18. Marks R, Ronnie G, Selwood TS. Malignant transformation of solar keratosis to squamous cell carcinoma. Lancet. 1988;I:795-7.
19. Farmer KC, Naylor MF. Sun exposure, sunscreens, and skin cancer prevention: A year round concern. Ann Pharmacother. 1996;30:662-73.
20. Marks R, Motley RJ. Skin cancer: recognition and treatment. Drugs. 1995;50:48-61.
21. Marks R, Foley P, Goodman G, et al. Spontaneous remission of solar keratosis: The case for conservative management. Br J Dermatol. 1986;115:649-55.
22. Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol. 2000;42:S25-8.
23. Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol. 1982;7:631-2.
24. Chiarello SE. Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses. An update and comparison. Dermatol Surg. 2000;8:728-32.
25. Schwartz RA. Therapeutic perspective in actinic and other keratoses. Int J Dermatol. 1996;35:533-8.
26. Kuflik EG. Cryosurgery updated. J Am Acad Dermatol. 1994;31:925-34.
27. Goette DK. Topical chemotherapy with 5 flurouracil. A review. J Am Acad Dermatol. 1981;4:633-49.
28. Robinson TA, Kligman AM. Treatment of solar keratoses of the extremities with retinoic acid and 5-flurouracil. Br J Dermatol. 1975;92:703-6.
29. Bercovitch L. Topical chemotherapy of actinic keratoses of the upper extremity with tretinoin and 5-flurouracil: A double-blind controlled study. Br J Dermatol. 1987;116:549-52.
30. Epstein E. Does intermittent pulse topical 5 flurouracil therapy allow destruction of actinic keratoses without significant inflammation. J Am Acad Dermatol. 1998;38:77-80.
31. Lawrence N, Cox SE, Clay J, et al. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% flurouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol. 1995;131:176-81.
32. Coleman WP, Yarborough JM, Mandy SH. Dermabrasion for prophylaxis and treatment of actinic keratosis. Dermatol Surg. 1996;22:17-21.
33. Fitzpatrick R, Goldman MP, Satur NM, et al. Pulsed carbon dioxide laser resurfacing of photo damaged skin. Arch Dermatol. 1996;132:395-402.
34. Spicer MS, Goldberg DJ. Lasers in dermatology. J Am Acad Dermatol. 1996;34:1-25.
35. Jeffes EWB, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical 5-aminolevulonic acid. A pilot dose-ranging study. Arch Dermatol. 1997;133:727-32.
36. Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-flurouracil in the treatment of actinic keratosis. J Am Acad Dermatol. 1999;41:414-8.
37. Beutner KR, Geisse JK, Helman D, et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol. 1999;41:1002-7.
38. Rivers JK, McLean DI. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses. Arch Dermatol. 1997;133:1239-42.
39. Peters DC, Foster RH. Diclofenac/hyaluronic acid. Drugs Aging. 1999;14:313-21.
40. Dufresne RG, Curlin MU. Actinic cheilitis: A treatment review. Dermatol Surg. 1997;23:15-21.
41. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl Med J. 1993;329:1147-51.
42. Naylor MF, Boyd A, Smith DW, et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995;131:170-5.
43. Kligman AM, Thorne EG. Topical therapy of actinic keratoses with tretinoin. In: Marks R, ed. Retinoids in Cutaneous Malignancy. Oxford, Blackwell Scientific Publications; 1991:66-73.